MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 269 filers reported holding MYRIAD GENETICS INC in Q3 2013. The put-call ratio across all filers is 2.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $36,000 | -12.2% | 3,157 | +10.0% | 0.00% | -100.0% |
| Q1 2020 | $41,000 | -26.8% | 2,870 | +38.4% | 0.00% | 0.0% |
| Q4 2019 | $56,000 | -99.0% | 2,074 | -98.9% | 0.00% | -98.0% |
| Q3 2019 | $5,530,000 | +12.1% | 193,162 | +8.8% | 0.05% | +13.3% |
| Q2 2019 | $4,931,000 | +4.4% | 177,498 | +24.8% | 0.04% | +12.5% |
| Q1 2019 | $4,722,000 | +1380.3% | 142,231 | +1194.8% | 0.04% | +1233.3% |
| Q4 2018 | $319,000 | -89.8% | 10,985 | -83.8% | 0.00% | -86.4% |
| Q3 2018 | $3,118,000 | +23.5% | 67,773 | +0.3% | 0.02% | +29.4% |
| Q2 2018 | $2,524,000 | +26.6% | 67,548 | +0.2% | 0.02% | +21.4% |
| Q1 2018 | $1,993,000 | +111.8% | 67,432 | +146.2% | 0.01% | +133.3% |
| Q4 2017 | $941,000 | -4.9% | 27,389 | +0.1% | 0.01% | -14.3% |
| Q3 2017 | $990,000 | -46.8% | 27,355 | -69.7% | 0.01% | -41.7% |
| Q3 2016 | $1,860,000 | -93.5% | 90,369 | -90.4% | 0.01% | -93.7% |
| Q2 2016 | $28,687,000 | -40.3% | 937,498 | -27.0% | 0.19% | -37.3% |
| Q1 2016 | $48,086,000 | -21.3% | 1,284,698 | -9.2% | 0.30% | -17.0% |
| Q4 2015 | $61,067,000 | -28.3% | 1,414,898 | -37.7% | 0.36% | -19.1% |
| Q3 2015 | $85,142,000 | -11.3% | 2,271,668 | -19.5% | 0.45% | +11.4% |
| Q2 2015 | $95,961,000 | -20.4% | 2,823,203 | -17.1% | 0.40% | -11.2% |
| Q1 2015 | $120,509,000 | -30.4% | 3,404,200 | -33.0% | 0.46% | -24.1% |
| Q4 2014 | $173,180,000 | -49.6% | 5,084,563 | -42.9% | 0.60% | -48.2% |
| Q3 2014 | $343,507,000 | -5.1% | 8,906,065 | -4.2% | 1.16% | +7.7% |
| Q2 2014 | $361,936,000 | +12.2% | 9,299,478 | -1.4% | 1.08% | +13.0% |
| Q1 2014 | $322,607,000 | +41.8% | 9,435,713 | -13.0% | 0.95% | +46.2% |
| Q4 2013 | $227,488,000 | -12.0% | 10,843,075 | -1.5% | 0.65% | -15.2% |
| Q3 2013 | $258,655,000 | -10.4% | 11,006,575 | +2.4% | 0.77% | -13.8% |
| Q2 2013 | $288,702,000 | – | 10,744,395 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |